The Neonatal And Preterm Infants Enteral Feeding Devices Market, estimated at USD 3.59 Bn in 2025, is expected to exhibit a CAGR of 5.1% and reach USD 5.09 Bn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
The major players operating in the market are focused on the launch of awareness campaigns. For instance, on February 5, 2023, ausEE Inc., Australia based charity, announced that it had organized an awareness campaign from 5-11 February 2023, to increase awareness and understanding in the community by raising some of the challenges faced and highlighting the day-to-day impact of tube feeding on individuals, carers and families.
Global Neonatal and Preterm Infants Enteral Feeding Devices Market - Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and consequent lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The pandemic hampered the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that was significantly impacted by the COVID-19 pandemic.
Many patients suffering from COVID-19 had a severe respiratory infection that required hospitalization and mechanical ventilation. Governments of various countries are focusing on initiatives to fight against the COVID-19 pandemic and stop the spread of the coronavirus infection by implementing various measures in the countries. Moreover, the governments of various countries have collaborated with universities around the globe to find novel treatments option for COVID-19 and its related complications. For instance, in March 2022, according to the data published by National Center for Biotechnology Information, patients who are critically ill with COVID-19 have impaired nutrient absorption due to disruption of the normal intestinal mucosa. They are often in a state of high inflammation, increased stress, and catabolism as well as a significant increase in energy and protein requirements. Therefore, timely enteral nutrition support and the provision of optimal nutrients are essential in preventing malnutrition in these patients
Global Neonatal and Preterm Infants Enteral Feeding Devices Market: Key Developments
Increasing number of premature infants is expected to aid in the growth of the neonatal and preterm infants enteral feeding devices market. For instance, according to the data provided by the Centers for Disease Control and Prevention, in November 2022, preterm birth affected about 1 of every 10 infants born in the U.S., in 2021
Moreover, according to an article published by Thieme Medical Publishers, an international medical and science publisher, in July 2020, an unblinded pilot randomized clinical trial on hemodynamically stable preterm infants (>28 weeks) recruited from level 2 neonatal intensive care unit at Mansoura University Children's Hospital, a healthcare organization in Mansurah, Egypt, was carried out. According to the results of the clinical trial, preterm infants without any respiratory support receiving bolus nasogastric tube feeding achieved full enteral feeding significantly sooner than those receiving bolus orogastric tube feeding. Additionally, bolus nasogastric tube feeding had a lower incidence of aspiration and tube displacement, and the infants regained birth weight more quickly than those receiving orogastric tube feeding.